aTYR PHARMA (ATYR) Accumulated Expenses (2014 - 2026)
aTYR PHARMA's Accumulated Expenses came in at $6.69 million for Q2 2026, down 35.2% from $10.32 million a year earlier and down 10.3% from the prior quarter.
Powered by 
Analysis
aTYR PHARMA (ATYR) Accumulated Expenses (2014 - 2026) Analysis & Trends
At the end of FY2025, aTYR PHARMA's Accumulated Expenses was $9.79 million, up 4.2% from FY2024.
- Accumulated Expenses carries a five-year compound annual growth rate of 22.3% (FY2020 to FY2025).
- Going back by year, Accumulated Expenses was $9.39 million in FY2024 (-18.7%), $11.56 million in FY2023 (+17.2%), $9.86 million in FY2022 (+146.4%) and $4 million in FY2021 (+12.0%).
- The Q2 2026 figure represents the lowest quarterly Accumulated Expenses since Q2 2022.
- Year-over-year, Accumulated Expenses increased in three of the last eight quarters, with an average decline of 7.4%.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q4 2022 (growth of 146.4%), and the weakest in Q2 2026 (a decline of 35.2%).
- Business Quant data shows ATYR's Accumulated Expenses at $7.46 million (Q1 2026), $9.79 million (Q4 2025) and $10.19 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | aTYR PHARMA | 16.86 Mn | -275.96 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.69 Mn |
| Mar 31, 2026 | 7.46 Mn |
| Dec 31, 2025 | 9.79 Mn |
| Sep 30, 2025 | 10.19 Mn |
| Jun 30, 2025 | 10.32 Mn |
| Mar 31, 2025 | 7.86 Mn |
| Dec 31, 2024 | 9.39 Mn |
| Sep 30, 2024 | 8.96 Mn |
| Jun 30, 2024 | 9.41 Mn |
| Mar 31, 2024 | 9.95 Mn |
| Dec 31, 2023 | 11.56 Mn |
| Sep 30, 2023 | 9.61 Mn |
| Jun 30, 2023 | 10.79 Mn |
| Mar 31, 2023 | 8.89 Mn |
| Dec 31, 2022 | 9.86 Mn |
| Sep 30, 2022 | 7.27 Mn |
| Jun 30, 2022 | 6.61 Mn |
| Mar 31, 2022 | 3.69 Mn |
| Dec 31, 2021 | 4.00 Mn |
| Sep 30, 2021 | 3.97 Mn |
API Access
aTYR PHARMA Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ATYR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ATYR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ATYR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();